Lucid Diagnostics EPS History: Annual & Quarterly (LUCD)

Lucid Diagnostics's diluted EPS was -$0.43 for fiscal 2025.

View full Lucid Diagnostics company overview

Lucid Diagnostics annual diluted eps history

Lucid Diagnostics annual diluted eps

Diluted EPSBasic EPS
Fiscal yearPeriod endedDiluted EPSBasic EPSChangeGrowth
20252025-12-31-$0.43-$0.69$0.62
20242024-12-31-$1.05-$1.05$0.21
20232023-12-31-$1.26-$1.26$0.29
20222022-12-31-$1.55-$1.55-$0.04
20212021-12-31-$1.51-$1.51-$0.92
20202020-12-31-$0.59-$0.59

Lucid Diagnostics diluted eps trends

Over the last five fiscal years, Lucid Diagnostics's diluted eps increased from -$0.59 to -$0.43, a change of $0.16. The latest reported quarter, Q2 2026, shows -$0.08.

About the metric

What earnings per share (EPS) means

Earnings per share (EPS) shows how much profit or loss is attributable to each common share. Diluted EPS includes the potential effect of convertible securities, options, and other instruments that could increase the share count, while basic EPS uses the weighted-average common shares actually outstanding.

Calculation and source

SEC-reported diluted and basic EPS

TickerStat displays diluted and basic earnings per share from SEC filings. Historical EPS values are adjusted to the current share basis when SEC-reported stock-split conversion ratios are available; they are not analyst estimates or earnings forecasts. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Lucid Diagnostics source filings ↗

Community posts

It’s quiet here.

No posts about LUCD yet. Start the conversation.

Write the first post